Wall Street Zen Upgrades China Pharma (NYSE:CPHI) to Hold

China Pharma (NYSE:CPHI) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Wednesday.

China Pharma Trading Down 1.3%

Shares of NYSE CPHI opened at $2.21 on Wednesday. The business has a 50-day moving average of $10.50 and a 200-day moving average of $17.39. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. China Pharma has a fifty-two week low of $1.20 and a fifty-two week high of $3.35.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.